Stanley Druckenmiller's BLTE Position Overview
Stanley Druckenmiller (via Duquesne Family Office LLC) currently holds 106,100 shares of Belite Bio, Inc (BLTE) worth $16.92 M, representing 0.50% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Stanley Druckenmiller has initiated a new position in BLTE, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Stanley Druckenmiller's Belite Bio (BLTE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Belite Bio (BLTE) Trades by Stanley Druckenmiller
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +106,100 | New Buy | 106,100 | $159.44 |
Stanley Druckenmiller's Belite Bio Investment FAQs
Stanley Druckenmiller first purchased Belite Bio, Inc (BLTE) in Q1 2026, acquiring 106,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Stanley Druckenmiller has held Belite Bio, Inc (BLTE) for 1 quarters since Q1 2026.
Stanley Druckenmiller's largest addition to Belite Bio, Inc (BLTE) was in Q1 2026, adding 106,100 shares worth $16.92 M.
According to the latest 13F filing for Q1 2026, Stanley Druckenmiller's firm, Duquesne Family Office LLC, owns 106,100 shares of Belite Bio, Inc (BLTE), valued at approximately $16.92 M.
As of the Q1 2026 filing, Belite Bio, Inc (BLTE) represents approximately 0.50% of Stanley Druckenmiller's publicly disclosed stock portfolio, making it one of their key holdings.
Stanley Druckenmiller's peak holding in Belite Bio, Inc (BLTE) was 106,100 shares, as reported at the end of Q1 2026.